Insider Buy/Sell Details for the Healthcare Sector — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1784)
UNITED THERAPEUTICS Corp (UTHR)
MALCOLM JAN — Director
Shares
325
Price
$550.59
Total Value
$178.94K
Shares Held After
450
% of Holdings
41.9%
VIVOS INC (RDGL)
Weeks Brad Allan — President
Shares
12,000
Price
$0.08
Total Value
$960.00
Shares Held After
999,235
% of Holdings
1.2%
4D Molecular Therapeutics, Inc. (FDMT)
Kirn David — Director
Shares
42,608
Price
$12.87
Total Value
$548.18K
Shares Held After
899,877
% of Holdings
4.5%
FORUM MARKETS Inc (FRMM)
Lomashuk Konstantin — 10% Owner
Shares
3,387
Price
$6.15
Total Value
$20.85K
Shares Held After
1,479,200
% of Holdings
0.2%
GLAUKOS Corp (GKOS)
Thurman Alex R. — SVP & CHIEF FINANCIAL OFFICER
Shares
10,000
Price
$155.00
Total Value
$1.55M
Shares Held After
43,681
% of Holdings
18.6%
Boundless Bio, Inc. (BOLD)
TANG KEVIN — 10% Owner
Shares
7
Price
$2.48
Total Value
$17.36
Shares Held After
2,698,525
% of Holdings
0.0%
Arcus Biosciences, Inc. (RCUS)
Jaen Juan C. — President
Shares
48,502
Price
$30.05
Total Value
$1.46M
Shares Held After
842,307
% of Holdings
5.4%
PTC THERAPEUTICS, INC. (PTCT)
Almstead Neil Gregory — CHIEF TECHNICAL OPS OFFICER
Shares
2,464
Price
$90.25
Total Value
$222.38K
Shares Held After
60,299
% of Holdings
3.9%
PTC THERAPEUTICS, INC. (PTCT)
Smith Mary L. — Director
Shares
5,834
Price
$90.00
Total Value
$525.06K
Shares Held After
21,813
% of Holdings
21.1%
PTC THERAPEUTICS, INC. (PTCT)
Smith Mary L. — Director
Shares
10,000
Price
$90.00
Total Value
$900.00K
Shares Held After
21,813
% of Holdings
31.4%
BridgeBio Pharma, Inc. (BBIO)
Cook Jennifer E. — Director
Shares
112,422
Price
$90.00
Total Value
$10.12M
Shares Held After
8,383
% of Holdings
93.1%
BridgeBio Pharma, Inc. (BBIO)
Cook Jennifer E. — Director
Shares
36,167
Price
$84.00
Total Value
$3.04M
Shares Held After
120,805
% of Holdings
23.0%
BridgeBio Pharma, Inc. (BBIO)
Ellis Andrea — Director
Shares
17,167
Price
$84.00
Total Value
$1.44M
Shares Held After
22,579
% of Holdings
43.2%
BillionToOne, Inc. (BLLN)
Atay Oguzhan — Director
Shares
352
Price
$128.23
Total Value
$45.14K
Shares Held After
0
% of Holdings
100.0%
BillionToOne, Inc. (BLLN)
Atay Oguzhan — Director
Shares
2,657
Price
$127.44
Total Value
$338.60K
Shares Held After
352
% of Holdings
88.3%
BillionToOne, Inc. (BLLN)
Atay Oguzhan — Director
Shares
2,002
Price
$126.48
Total Value
$253.22K
Shares Held After
3,009
% of Holdings
40.0%
BillionToOne, Inc. (BLLN)
Atay Oguzhan — Director
Shares
7,489
Price
$125.43
Total Value
$939.32K
Shares Held After
5,011
% of Holdings
59.9%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Savitz Ryan — EVP, CFO & CBO
Shares
5,566
Price
$101.97
Total Value
$567.57K
Shares Held After
0
% of Holdings
100.0%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Savitz Ryan — EVP, CFO & CBO
Shares
15,329
Price
$101.24
Total Value
$1.55M
Shares Held After
5,566
% of Holdings
73.4%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Savitz Ryan — EVP, CFO & CBO
Shares
10,354
Price
$100.22
Total Value
$1.04M
Shares Held After
20,895
% of Holdings
33.1%
BillionToOne, Inc. (BLLN)
Sakakibara Shan Riku — Chief Product Officer
Shares
1,354
Price
$125.00
Total Value
$169.25K
Shares Held After
204,000
% of Holdings
0.7%
BillionToOne, Inc. (BLLN)
Sakakibara Shan Riku — Chief Product Officer
Shares
1,355
Price
$125.00
Total Value
$169.38K
Shares Held After
205,354
% of Holdings
0.7%
BillionToOne, Inc. (BLLN)
Sakakibara Shan Riku — Chief Product Officer
Shares
1,117
Price
$125.00
Total Value
$139.62K
Shares Held After
206,709
% of Holdings
0.5%
BillionToOne, Inc. (BLLN)
Sakakibara Shan Riku — Chief Product Officer
Shares
174
Price
$125.00
Total Value
$21.75K
Shares Held After
207,826
% of Holdings
0.1%
BillionToOne, Inc. (BLLN)
Sakakibara Shan Riku — Chief Product Officer
Shares
4,000
Price
$125.00
Total Value
$500.00K
Shares Held After
208,000
% of Holdings
1.9%
NEUROCRINE BIOSCIENCES INC (NBIX)
Lippoldt Darin — Chief Legal Officer
Shares
10,000
Price
$179.60
Total Value
$1.80M
Shares Held After
54,729
% of Holdings
15.4%
Twist Bioscience Corp (TWST)
Laponis Adam — Chief Financial Officer
Shares
2,399
Price
$94.33
Total Value
$226.31K
Shares Held After
110,276
% of Holdings
2.1%
COMPUGEN LTD (CGEN)
Levine Zurit — SVP, Business Development
Shares
1,875
Price
$2.50
Total Value
$4.69K
Shares Held After
29,375
% of Holdings
6.0%
Privia Health Group, Inc. (PRVA)
Mountcastle David — EVP & Chief Financial Officer
Shares
21,275
Price
$27.67
Total Value
$588.68K
Shares Held After
164,853
% of Holdings
11.4%
Amylyx Pharmaceuticals, Inc. (AMLX)
Mazzariello Gina — Chief Legal Officer
Shares
15,000
Price
$18.32
Total Value
$274.75K
Shares Held After
194,090
% of Holdings
7.2%
Bluejay Diagnostics, Inc. (BJDX)
HRT FINANCIAL LP — 10% Owner
Shares
64,047
Price
$1.51
Total Value
$96.71K
Shares Held After
126,993
% of Holdings
50.4%
Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
HRT FINANCIAL LP — 10% Owner
Shares
8,266
Price
$3.38
Total Value
$27.94K
Shares Held After
60,540
% of Holdings
13.7%
ADIAL PHARMACEUTICALS, INC. (ADIL)
Coastlands Capital LP — 10% Owner
Shares
10,053
Price
$2.79
Total Value
$28.05K
Shares Held After
383,375
% of Holdings
2.6%
ProQR Therapeutics N.V. (PRQR)
de Boer Daniel Anton — Director
Shares
150,000
Price
$1.74
Total Value
$261.00K
Shares Held After
300,000
% of Holdings
50.0%
Mineralys Therapeutics, Inc. (MLYS)
Rodman David Malcom — Chief Medical Officer
Shares
2,171
Price
$30.30
Total Value
$65.78K
Shares Held After
57,733
% of Holdings
3.6%
PALISADE BIO, INC. (PALI)
Baltera Robert Jr. — Director
Shares
25,000
Price
$1.96
Total Value
$48.90K
Shares Held After
461,904
% of Holdings
5.4%
BioCardia, Inc. (BCDA)
Altman Peter — Director
Shares
1,000
Price
$0.90
Total Value
$900.00
Shares Held After
368,485
% of Holdings
0.3%
Contineum Therapeutics, Inc. (CTNM)
Lorrain Daniel S. — Chief Scientific Officer
Shares
25
Price
$16.00
Total Value
$400.00
Shares Held After
135,202
% of Holdings
0.0%
Bicara Therapeutics Inc. (BCAX)
Cohlhepp Ryan — Director
Shares
536
Price
$29.00
Total Value
$15.54K
Shares Held After
181,641
% of Holdings
0.3%
Nuvalent, Inc. (NUVL)
Pelish Henry E. — Chief Scientific Officer
Shares
2,111
Price
$123.81
Total Value
$261.36K
Shares Held After
63,493
% of Holdings
3.2%
INSMED Inc (INSM)
Lewis William — Director
Shares
3,359
Price
$118.52
Total Value
$398.11K
Shares Held After
259,058
% of Holdings
1.3%
INSMED Inc (INSM)
Lewis William — Director
Shares
2,335
Price
$117.62
Total Value
$274.64K
Shares Held After
262,417
% of Holdings
0.9%
INSMED Inc (INSM)
Lewis William — Director
Shares
5,005
Price
$116.55
Total Value
$583.33K
Shares Held After
264,752
% of Holdings
1.9%
UroGen Pharma Ltd. (URGN)
Schoenberg Mark — Chief Medical Officer
Shares
10,000
Price
$40.00
Total Value
$400.00K
Shares Held After
119,763
% of Holdings
7.7%
VIVOS INC (RDGL)
Weeks Brad Allan — President
Shares
48,000
Price
$0.08
Total Value
$3.84K
Shares Held After
987,235
% of Holdings
4.9%
Hinge Health, Inc. (HNGE)
Insight Holdings Group, LLC — 10% Owner
Shares
443
Price
$91.00
Total Value
$40.31K
Shares Held After
0
% of Holdings
100.0%
Hinge Health, Inc. (HNGE)
Insight Holdings Group, LLC — 10% Owner
Shares
2,289
Price
$91.00
Total Value
$208.30K
Shares Held After
0
% of Holdings
100.0%
Hinge Health, Inc. (HNGE)
Insight Holdings Group, LLC — 10% Owner
Shares
66
Price
$91.00
Total Value
$6.01K
Shares Held After
0
% of Holdings
100.0%
Hinge Health, Inc. (HNGE)
Insight Holdings Group, LLC — 10% Owner
Shares
2,792
Price
$91.00
Total Value
$254.07K
Shares Held After
0
% of Holdings
100.0%
Hinge Health, Inc. (HNGE)
Insight Holdings Group, LLC — 10% Owner
Shares
13,935
Price
$90.17
Total Value
$1.26M
Shares Held After
443
% of Holdings
96.9%
Showing 351–400 of 1784 transactions (page 8 of 36)